Zenyth Partners (Zenyth), a healthcare-focused private equity firm specialising in consumer-facing and tech-enabled healthcare services, has closed a continuation fund composed of both secondary and primary capital commitments, co-led by funds managed by BlackRock and Manulife Investment Management with support from Newbury Partners.
The fund has acquired minority stakes in three portfolio companies (the Sale Portfolio) from Zenyth Partners, LP, a 2018 vintage permanent capital vehicle. Each of the Sale Portfolio companies were founded by the Zenyth team.
The transaction represents a strong outcome for Zenyth Partners, LP and affiliates by more than fully returning capital invested in the Sale Portfolio at a valuation representing over 4x MOIC. The Zenyth General Partnership reinvested the entirety of its capital investment and proceeds realised from the transaction and committed additional new capital given its continued conviction in the Sale Portfolio.
Read more: Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.